NCT01957839|CompletedPhase 4
Loading search results
Sponsor study identifier
Secondary identifiers
OTHER · Doppler
interventional
48
1 country
1
Study Start
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2011
Actual (reported)Study Completion
September 2011
Actual (reported)the investigators examined the hypothesis that hyperprolactinemia may alter uterin, endometrial and intraovarian blood flow and may contribute to increased infertility by another way.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
August 2011
Actual (reported)September 2011
Actual (reported)September 10, 2013
Actual (reported)October 8, 2013
Actual (reported)th effect of prolactin vascular flow and resistance
the effect of prolactin in vascular resistance at 2 weeks after treatment
doppler evaluation at pretreatment period
doppler evaluatıon in normoprolactinemia women who given cabergoline treatment
Sisli Etfal Teaching Hosital
Şişli, Turkey (Türkiye)
Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K, Izumi S, Okada Y, Hori T. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab. 2010 Jun;95(6):2672-9. doi: 10.1210/jc.2009-2605. Epub 2010 Mar 31.
Temizkan O, Temizkan S, Asicioglu O, Aydin K, Kucur S. Color Doppler analysis of uterine, spiral, and intraovarian artery blood flow before and after treatment with cabergoline in hyperprolactinemic patients. Gynecol Endocrinol. 2015 Jan;31(1):75-8. doi: 10.3109/09513590.2014.958989. Epub 2014 Sep 15.
Osman Temizkan, M.D.
SİSLİ ETFAL TEACHİNG HOSPİTAL
48 participants (actual enrollment reported by the registry).
First Submitted
September 10, 2013
First Posted
October 8, 2013
Study Start
March 2010
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
Contact the study team to confirm eligibility.
Primary Completion
August 2011
Actual (reported)Study Completion
September 2011
Actual (reported)Last Updated
October 8, 2013
Record last verified: 2013-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: